Deciphering mechanisms controlling placental artery endothelial cell migration stimulated by vascular endothelial growth factor

Endocrinology

Volumn 151, Issue 7, 2010, Pages 3432-3444

  Liao, Wu Xiang ^a   Feng, Lin ^a   Zheng, Jing ^b   Chen, Dong Bao ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; 4 AMINO 7 TERT BUTYL 5 (4 CHLOROPHENYL)PYRAZOLO[3,4 D]PYRIMIDINE; ACTIN; ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; BETA ACTIN; CAVEOLIN 1; COFILIN 1; DIETHYLENETRIAMINE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; FOCAL ADHESION KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE 9; MITOGEN ACTIVATED PROTEIN KINASE P38; NITRIC OXIDE; PAXILLIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN AKT1; PROTEIN KINASE B; STRESS ACTIVATED PROTEIN KINASE 1; UNCLASSIFIED DRUG; VASCULOTROPIN; WORTMANNIN; 1,3 BUTADIENE DERIVATIVE; ANDROSTANE DERIVATIVE; ANTHRA(1,9 CD)PYRAZOL 6(2H) ONE; ANTHRA(1,9-CD)PYRAZOL-6(2H)-ONE; ANTHRACENE DERIVATIVE; ENZYME INHIBITOR; IMIDAZOLE DERIVATIVE; NITRILE; NITROGEN OXIDE; PROTEIN TYROSINE KINASE; PROTEIN TYROSINE KINASE C SRC; PROTEIN-TYROSINE KINASE C-SRC; PYRIDINE DERIVATIVE; PYRIMIDINE DERIVATIVE; STRESS ACTIVATED PROTEIN KINASE; VASCULOTROPIN A;

ANIMAL CELL; ARTICLE; CELL MIGRATION; CONTROLLED STUDY; COW; DOWN REGULATION; ENDOTHELIUM CELL; ENZYME INHIBITION; FEMALE; FETOPLACENTAL UNIT; FOCAL ADHESION; NONHUMAN; ONCOGENE SRC; PLACENTA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; STRESS FIBER; ANIMAL; ARTERY; CELL CULTURE; CELL MOTION; CYTOLOGY; DRUG ANTAGONISM; DRUG EFFECT; GENETICS; IMMUNOPRECIPITATION; METABOLISM; POLYACRYLAMIDE GEL ELECTROPHORESIS; PREGNANCY; SHEEP; VASCULARIZATION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANDROSTADIENES; ANIMALS; ANTHRACENES; ARTERIES; BUTADIENES; CAVEOLIN 1; CELL MOVEMENT; CELLS, CULTURED; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ENDOTHELIAL CELLS; ENZYME INHIBITORS; FEMALE; FOCAL ADHESION PROTEIN-TYROSINE KINASES; IMIDAZOLES; IMMUNOPRECIPITATION; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; NITRIC OXIDE SYNTHASE TYPE III; NITRILES; NITROGEN OXIDES; PLACENTA; PREGNANCY; PROTEIN-TYROSINE KINASES; PYRIDINES; PYRIMIDINES; SHEEP; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 77954616807     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2009-1305     Document Type: Article

References (85)

1. Carmeliet P 2000 Mechanisms of angiogenesis and arteriogenesis. Nat Med 6:389-395
2. Reynolds LP, Redmer DA 2001 Angiogenesis in the placenta. Biol Reprod 64:1033-1040
3. Magness R 1999 Maternal cardiovascular and other physiologic responses to the endocrinology of pregnancy. In: Bazer F, ed. The endocrinology of pregnancy. Totowa, NJ: Human Press Inc.; 507-539
4. Zhou Y, McMaster M, Woo K, Janatpour M, Perry J, Karpanen T, Alitalo K, Damsky C, Fisher SJ 2002 Vascular endothelial growth factor ligands and receptors that regulate human cytotrophoblast survival are dysregulated in severe preeclampsia and hemolysis, elevated liver enzymes, and low platelets syndrome. Am J Pathol 160:1405-1423
5. Maynard SE, Min JY, Merchan J, Lim KH, Li J, Mondal S, Libermann TA, Morgan JP, Sellke FW, Stillman IE, Epstein FH, Sukhatme VP, Karumanchi SA 2003 Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest 111:649-658
6. Zheng J, Vagnoni KE, Bird IM, Magness RR 1997 Expression of basic fibroblast growth factor, endothelial mitogenic activity, and angiotensin II type 1 receptors in the ovine placenta during the third trimester of pregnancy. Biol Reprod 56:1189-1197
7. Borowicz PP, Arnold DR, Johnson ML, Grazul-Bilska AT, Redmer DA, Reynolds LP 2007 Placental growth throughout the last two thirds of pregnancy in sheep: vascular development and angiogenic factor expression. Biol Reprod 76:259-267
8. Cheung CY, Brace RA 1999 Developmental expression of vascular endothelial growth factor and its receptors in ovine placenta and fetal membranes. J Soc Gynecol Investig 6:179-185
9. Zheng J, Wen Y, Austin JL, Chen DB 2006 Exogenous nitric oxide stimulates cell proliferation via activation of a mitogen-activated protein kinase pathway in ovine fetoplacental artery endothelial cells. Biol Reprod 74:375-382
10. Ferrara N, Gerber HP, LeCouter J 2003 The biology of VEGF and its receptors. Nat Med 9:669-676
11. Zheng J, Bird IM, Melsaether AN, Magness RR 1999 Activation of the mitogen-activated protein kinase cascade is necessary but not sufficient for basic fibroblast growth factor- and epidermal growth factor-stimulated expression of endothelial nitric oxide synthase in ovine fetoplacental artery endothelial cells. Endocrinology 140:1399-1407
12. Zheng J, Wen Y, Song Y, Wang K, Chen DB, Magness RR 2008 Activation of multiple signaling pathways is critical for fibroblast growth factor 2- and vascular endothelial growth factor-stimulated ovine fetoplacental endothelial cell proliferation. Biol Reprod 78:143-150
13. Mata-Greenwood E, Liao WX, Zheng J, Chen DB 2008 Differential activation of multiple signalling pathways dictates eNOS upregulation by FGF2 but not VEGF in placental artery endothelial cells. Placenta 29:708-717
14. Liao WX, Feng L, Zhang H, Zheng J, Moore TR, Chen DB 2009 Compartmentalizing VEGF-induced ERK2/1 signaling in placental artery endothelial cell caveolae: a paradoxical role of caveolin-1 in placental angiogenesis in vitro. Mol Endocrinol 23:1428-1444
15. Lamalice L, Le Boeuf F, Huot J 2007 Endothelial cell migration during angiogenesis. Circ Res 100:782-794
16. Huang C, Jacobson K, Schaller MD 2004 MAP kinases and cell migration. J Cell Sci 117:4619-4628
17. Kim MP, Park SI, Kopetz S, Gallick GE 2009 Src family kinases as mediators of endothelial permeability: effects on inflammation and metastasis. Cell Tissue Res 335:249-259
18. Palade GE, Bruns RR 1968 Structural modulations of plasmalemmal vesicles. J Cell Biol 37:633-649
19. Doherty GJ, McMahon HT 2009 Mechanisms of endocytosis.Annu Rev Biochem 78:857-902
20. Smart EJ, Li XA 2007 Hyperglycemia: cell death in a cave. Biochim Biophys Acta 1772:524-526
21. Pani B, Singh BB 2009 Lipid rafts/caveolae as microdomains of calcium signaling. Cell Calcium 45:625-633
22. Grande-García A, Echarri A, de Rooij J, Alderson NB, Waterman-Storer CM, Valdivielso JM, del Pozo MA 2007 Caveolin-1 regulates cell polarization and directional migration through Src kinase and Rho GTPases. J Cell Biol 177:683-694
23. Sedding DG, Hermsen J, Seay U, Eickelberg O, Kummer W, Schwencke C, Strasser RH, Tillmanns H, Braun-Dullaeus RC 2005 Caveolin-1 facilitates mechanosensitive protein kinase B (Akt) signaling in vitro and in vivo. Circ Res 96:635-642
24. Mineo C, Shaul PW 2006 Circulating cardiovascular disease risk factors and signaling in endothelial cell caveolae. Cardiovasc Res 70:31-41
25. Okamoto T, Schlegel A, Scherer PE, Lisanti MP 1998 Caveolins, a family of scaffolding proteins for organizing "preassembled signaling complexes" at the plasma membrane. J Biol Chem 273:5419-5422
26. Liao WX, Magness RR, Chen DB 2005 Expression of estrogen receptors-α and -β in the pregnant ovine uterine artery endothelial cells in vivo and in vitro. Biol Reprod 72:530-537
27. Liao WX, Moore RK, Otsuka F, Shimasaki S 2003 Effect of intracellular interactions on the processing and secretion of bone morphogenetic protein-15 (BMP-15) and growth and differentiation factor-9. Implication of the aberrant ovarian phenotype of BMP-15 mutant sheep. J Biol Chem 278:3713-3719
28. Liang CC, Park AY, Guan JL 2007 In vitro scratch assay: a convenient and inexpensive method for analysis of cell migration in vitro. Nat Protoc 2:329-333
29. Favata MF, Horiuchi KY, Manos EJ, Daulerio AJ, Stradley DA, Feeser WS, Van Dyk DE, Pitts WJ, Earl RA, Hobbs F, Copeland RA, Magolda RL, Scherle PA, Trzaskos JM 1998 Identification of a novel inhibitor of mitogen-activated protein kinase kinase. J Biol Chem 273:18623-18632
30. Cuenda A, Rouse J, Doza YN, Meier R, Cohen P, Gallagher TF, Young PR, Lee JC 1995 SB 203580 is a specific inhibitor of a MAP kinase homologue which is stimulated by cellular stresses and interleukin-1. FEBS Lett 364:229-233
31. Bennett BL, Sasaki DT, Murray BW, O'Leary EC, Sakata ST, Xu W, Leisten JC, Motiwala A, Pierce S, Satoh Y, Bhagwat SS, Manning AM, Anderson DW 2001 SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase. Proc Natl Acad Sci USA 98:13681-13686
32. Hanke JH, Gardner JP, Dow RL, Changelian PS, Brissette WH, Weringer EJ, Pollok BA, Connelly PA 1996 Discovery of a novel, potent, and Src family-selective tyrosine kinase inhibitor. Study of Lck-and FynT-dependent T cell activation. J Biol Chem 271:695-701
33. Wymann MP, Bulgarelli-Leva G, Zvelebil MJ, Pirola L, Vanhaesebroeck B, Waterfield MD, Panayotou G 1996 Wortmannin inactivates phosphoinositide 3-kinase by covalent modification of Lys-802, a residue involved in the phosphate transfer reaction. Mol Cell Biol 16:1722-1733
34. Condeelis J 2001 How is actin polymerization nucleated in vivo? Trends Cell Biol 11:288-293
35. Kobayashi M, Nishita M, Mishima T, Ohashi K, Mizuno K 2006 MAPKAPK-2-mediated LIM-kinase activation is critical for VEGF-induced actin remodeling and cell migration. EMBO J 25:713-726
36. Schaller MD, Borgman CA, Cobb BS, Vines RR, Reynolds AB, Parsons JT 1992 pp125FAK a structurally distinctive protein-tyrosine kinase associated with focal adhesions. Proc Natl Acad Sci USA 89:5192-5196
37. Sieg DJ, Hauck CR, Ilic D, Klingbeil CK, Schaefer E, Damsky CH, Schlaepfer DD 2000 FAK integrates growth-factor and integrin signals to promote cell migration. Nat Cell Biol 2:249-256
38. Webb DJ, Donais K, Whitmore LA, Thomas SM, Turner CE, Parsons JT, Horwitz AF 2004 FAK-Src signalling through paxillin, ERK and MLCK regulates adhesion disassembly. Nat Cell Biol 6:154-161
39. Parri M, Buricchi F, Giannoni E, Grimaldi G, Mello T, Raugei G, Ramponi G, Chiarugi P 2007 Ephrin A1 activates a Src/focal adhesion kinase-mediated motility response leading to rho-dependent actino/myosin contractility. J Biol Chem 282:19619-19628
40. Turner CE 2000 Paxillin and focal adhesion signalling. Nat Cell Biol 2:E231-E236
41. Burridge K, Turner CE, Romer LH 1992 Tyrosine phosphorylation of paxillin and pp125FAK accompanies cell adhesion to extracellular matrix: a role in cytoskeletal assembly. J Cell Biol 119:893-903
42. src. Mol Cell Biol 14:1680-1688
43. Dimmeler S, Fleming I, Fisslthaler B, Hermann C, Busse R, Zeiher AM 1999 Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation. Nature 399:601-605
44. Fulton D, Gratton JP, McCabe TJ, Fontana J, Fujio Y, Walsh K, Franke TF, Papapetropoulos A, Sessa WC 1999 Regulation of endothelium-derived nitric oxide production by the protein kinase Akt. Nature 399:597-601
45. Murohara T, Asahara T, Silver M, Bauters C, Masuda H, Kalka C, Kearney M, Chen D, Symes JF, Fishman MC, Huang PL, Isner JM 1998 Nitric oxide synthase modulates angiogenesis in response to tissue ischemia. J Clin Invest 101:2567-2578
46. Fukumura D, Gohongi T, Kadambi A, Izumi Y, Ang J, Yun CO, Buerk DG, Huang PL, Jain RK 2001 Predominant role of endothelial nitric oxide synthase in vascular endothelial growth factor-induced angiogenesis and vascular permeability. Proc Natl Acad Sci USA 98:2604-2609
47. Lau YT, Ma WC 1996 Nitric oxide inhibits migration of cultured endothelial cells. Biochem Biophys Res Commun 221:670-674
48. Parat MO, Anand-Apte B, Fox PL 2003 Differential caveolin-1 polarization in endothelial cells during migration in two and three dimensions. Mol Biol Cell 14:3156-3168
49. Beardsley A, Fang K, Mertz H, Castranova V, Friend S, Liu J 2005 Loss of caveolin-1 polarity impedes endothelial cell polarization and directional movement. J Biol Chem 280:3541-3547
50. Sun XH, Flynn DC, Castranova V, Millecchia LL, Beardsley AR, Liu J 2007 Identification of a novel domain at the N terminus of caveolin-1 that controls rear polarization of the protein and caveolae formation. J Biol Chem 282:7232-7241
51. Becker PM, Verin AD, Booth MA, Liu F, Birukova A, Garcia JG 2001 Differential regulation of diverse physiological responses to VEGF in pulmonary endothelial cells. Am J Physiol Lung Cell Mol Physiol 281:L1500-L1511
52. Meadows KN, Bryant P, Pumiglia K 2001 Vascular endothelial growth factor induction of the angiogenic phenotype requires Ras activation. J Biol Chem 276:49289-49298
53. Rousseau S, Houle F, Landry J, Huot J 1997 p38 MAP kinase activation by vascular endothelial growth factor mediates actin reorganization and cell migration in human endothelial cells. Oncogene 15:2169-2177
54. Huang C, Rajfur Z, Borchers C, Schaller MD, Jacobson K 2003 JNK phosphorylates paxillin and regulates cell migration. Nature 424:219-223
55. Meadows KN, Bryant P, Vincent PA, Pumiglia KM 2004 Activated Ras induces a proangiogenic phenotype in primary endothelial cells. Oncogene 23:192-200
56. Han J, Lee JD, Tobias PS, Ulevitch RJ 1993 Endotoxin induces rapid protein tyrosine phosphorylation in 70Z/3 cells expressing CD14. J Biol Chem 268:25009-25014
57. Mudgett JS, Ding J, Guh-Siesel L, Chartrain NA, Yang L, Gopal S, Shen MM 2000 Essential role for p38α mitogen-activated protein kinase in placental angiogenesis. Proc Natl Acad Sci USA 97:10454-10459
58. Yu J, Bian D, Mahanivong C, Cheng RK, Zhou W, Huang S 2004 p38 Mitogen-activated protein kinase regulation of endothelial cell migration depends on urokinase plasminogen activator expression. J Biol Chem 279:50446-50454
59. McMullen ME, Bryant PW, Glembotski CC, Vincent PA, Pumiglia KM2005 Activation of p38 has opposing effects on the proliferation and migration of endothelial cells. J Biol Chem 280:20995-21003
60. Zhan Y, Kim S, Izumi Y, Izumiya Y, Nakao T, Miyazaki H, Iwao H 2003 Role of JNK, p38, and ERK in platelet-derived growth factor-induced vascular proliferation, migration, and gene expression. Arterioscler Thromb Vasc Biol 23:795-801
61. Rush S, Khan G, Bamisaiye A, Bidwell P, Leaver HA, Rizzo MT 2007 c-Jun amino-terminal kinase and mitogen activated protein kinase 1/2 mediate hepatocyte growth factor-induced migration of brain endothelial cells. Exp Cell Res 313:121-132
62. Bamburg JR 1999 Proteins of the ADF/cofilin family: essential regulators of actin dynamics. Annu Rev Cell Dev Biol 15:185-230
63. Morales-Ruiz M, Fulton D, Sowa G, Languino LR, Fujio Y, Walsh K, Sessa WC 2000 Vascular endothelial growth factor-stimulated actin reorganization and migration of endothelial cells is regulated via the serine/threonine kinase Akt. Circ Res 86:892-896
64. Kitamura T, Asai N, Enomoto A, Maeda K, Kato T, Ishida M, Jiang P, Watanabe T, Usukura J, Kondo T, Costantini F, Murohara T, Takahashi M 2008 Regulation of VEGF-mediated angiogenesis by the Akt/PKB substrate Girdin. Nat Cell Biol 10:329-337
65. Gong C, Stoletov KV, Terman BI 2004 VEGF treatment induces signaling pathways that regulate both actin polymerization and depolymerization. Angiogenesis 7:313-321
66. Katkade V, Soyombo AA, Isordia-Salas I, Bradford HN, Gaughan JP, Colman RW, Panetti TS 2005 Domain 5 of cleaved high molecular weight kininogen inhibits endothelial cell migration through Akt. Thromb Haemost 94:606-614
67. Brunton VG, Frame MC 2008 Src and focal adhesion kinase as therapeutic targets in cancer. Curr Opin Pharmacol 8:427-432
68. McMullen M, Keller R, Sussman M, Pumiglia K 2004 Vascular endothelial growth factor-mediated activation of p38 is dependent upon Src and RAFTK/Pyk2. Oncogene 23:1275-1282
69. Wang Y, Du D, Fang L, Yang G, Zhang C, Zeng R, Ullrich A, Lottspeich F, Chen Z 2006 Tyrosine phosphorylated Par3 regulates epithelial tight junction assembly promoted by EGFR signaling. EMBO J 25:5058-5070
70. Kim YB, Choi S, Choi MC, Oh MA, Lee SA, Cho M, Mizuno K, Kim SH, Lee JW 2008 Cell adhesion-dependent cofilin serine 3 phosphorylation by the integrin-linked kinase-c-Src complex. J Biol Chem 283:10089-10096
71. Duval M, Le Boeuf F, Huot J, Gratton JP 2007 Src-mediated phosphorylation of Hsp90 in response to vascular endothelial growth factor (VEGF) is required for VEGF receptor-2 signaling to endothelial NO synthase. Mol Biol Cell 18:4659-4668
72. Andreozzi F, Laratta E, Procopio C, Hribal ML, Sciacqua A, Perticone M, Miele C, Perticone F, Sesti G 2007 Interleukin-6 impairs the insulin signaling pathway, promoting production of nitric oxide in human umbilical vein endothelial cells. Mol Cell Biol 27:2372-2383
73. Labrecque L, Royal I, Surprenant DS, Patterson C, Gingras D, Béliveau R 2003 Regulation of vascular endothelial growth factor receptor-2 activity by caveolin-1 and plasma membrane cholesterol. Mol Biol Cell 14:334-347
74. Cai J, Ahmad S, Jiang WG, Huang J, Kontos CD, Boulton M, Ahmed A 2003 Activation of vascular endothelial growth factor receptor-1 sustains angiogenesis and Bcl-2 expression via the phosphatidylinositol 3-kinase pathway in endothelial cells. Diabetes 52:2959-2968
75. Navarro A, Anand-Apte B, Parat MO 2004 A role for caveolae in cell migration. FASEB J 18:1801-1811
76. Le Lay S, Kurzchalia TV 2005 Getting rid of caveolins: phenotypes of caveolin-deficient animals. Biochim Biophys Acta 1746:322-333
77. Bauer PM, Yu J, Chen Y, Hickey R, Bernatchez PN, Looft-Wilson R, Huang Y, Giordano F, Stan RV, Sessa WC 2005 Endothelial-specific expression of caveolin-1 impairs microvascular permeability and angiogenesis. Proc Natl Acad Sci USA 102:204-209
78. Sonveaux P, Martinive P, DeWever J, Batova Z, Daneau G, Pelat M, Ghisdal P, Grégoire V, Dessy C, Balligand JL, Feron O 2004 Caveolin-1 expression is critical for vascular endothelial growth factor-induced ischemic hindlimb collateralization and nitric oxide-mediated angiogenesis. Circ Res 95:154-161
79. Bucci M, Gratton JP, Rudic RD, Acevedo L, Roviezzo F, Cirino G, Sessa WC 2000 In vivo delivery of the caveolin-1 scaffolding domain inhibits nitric oxide synthesis and reduces inflammation. Nat Med 6:1362-1367
80. Yamaguchi T, Naruishi K, Arai H, Nishimura F, Takashiba S 2008 IL-6/sIL-6R enhances cathepsin B and L production via caveolin-1-mediated JNK-AP-1 pathway in human gingival fibroblasts. J Cell Physiol 217:423-432
81. Wang XM, Zhang Y, Kim HP, Zhou Z, Feghali-Bostwick CA, Liu F, Ifedigbo E, Xu X, Oury TD, Kaminski N, Choi AM 2006 Caveolin-1: a critical regulator of lung fibrosis in idiopathic pulmonary fibrosis. J Exp Med 203:2895-2906
82. Gonzalez E, Nagiel A, Lin AJ, Golan DE, Michel T 2004 Small interfering RNA-mediated down-regulation of caveolin-1 differentially modulates signaling pathways in endothelial cells. J Biol Chem 279:40659-40669
83. Li H, Nord EP 2004 Functional caveolae are a prerequisite for CD40 signaling in human renal proximal tubule cells. Am J Physiol Renal Physiol 286:F711-F719
84. Swaney JS, Patel HH, Yokoyama U, Head BP, Roth DM, Insel PA 2006 Focal adhesions in (myo)fibroblasts scaffold adenylyl cyclase with phosphorylated caveolin. J Biol Chem 281:17173-17179
85. Fulton D, Fontana J, Sowa G, Gratton JP, Lin M, Li KX, Michell B, Kemp BE, Rodman D, Sessa WC 2002 Localization of endothelial nitric-oxide synthase phosphorylated on serine 1179 and nitric oxide in Golgi and plasma membrane defines the existence of two pools of active enzyme. J Biol Chem 277:4277-4284